Nowadays kidney transplantation and dialysis are the only available therapies for end-stage renal disease management. They imply a considerable increase in plasma concentration of uremic wastes including creatinine, urea and uric acid. These invasive procedures impose high social costs that prevent many low-income countries from adequately treating the patients affected by renal insufficiency. For years, many studies on uremic waste removal through the gut lumen have been published with conflicting results. More recently, microencapsulation of probiotic bacteria has been performed by different research groups. This evidence has opened a new perspective on therapeutic modification of gut bacterial flora in the context of renal disease. This review gives an overview of the experimental and clinical use of probiotic formulations in the context of end-stage renal disease.

Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update / DI CERBO, Alessandro; Pezzuto, Federica; Palmieri, Lucia; Rottigni, Valentina; Iannitti, Tommaso; Palmieri, Beniamino. - In: INTERNATIONAL UROLOGY AND NEPHROLOGY. - ISSN 0301-1623. - ELETTRONICO. - 45:(2013), pp. 1569-1576. [10.1007/s11255-012-0335-5]

Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update

DI CERBO, Alessandro;PALMIERI, LUCIA;PALMIERI, Beniamino
2013

Abstract

Nowadays kidney transplantation and dialysis are the only available therapies for end-stage renal disease management. They imply a considerable increase in plasma concentration of uremic wastes including creatinine, urea and uric acid. These invasive procedures impose high social costs that prevent many low-income countries from adequately treating the patients affected by renal insufficiency. For years, many studies on uremic waste removal through the gut lumen have been published with conflicting results. More recently, microencapsulation of probiotic bacteria has been performed by different research groups. This evidence has opened a new perspective on therapeutic modification of gut bacterial flora in the context of renal disease. This review gives an overview of the experimental and clinical use of probiotic formulations in the context of end-stage renal disease.
45
1569
1576
Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update / DI CERBO, Alessandro; Pezzuto, Federica; Palmieri, Lucia; Rottigni, Valentina; Iannitti, Tommaso; Palmieri, Beniamino. - In: INTERNATIONAL UROLOGY AND NEPHROLOGY. - ISSN 0301-1623. - ELETTRONICO. - 45:(2013), pp. 1569-1576. [10.1007/s11255-012-0335-5]
DI CERBO, Alessandro; Pezzuto, Federica; Palmieri, Lucia; Rottigni, Valentina; Iannitti, Tommaso; Palmieri, Beniamino
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1060162
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 18
social impact